Engineering CAR-T cell therapies for digestive tract cancer: advances, challenges, and strategies to overcome tumor heterogeneity and immunosuppressive barriers
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Engineering CAR-T cell therapies for digestive tract cancer: advances, challenges, and strategies to overcome tumor heterogeneity and immunosuppressive barriers. // Neoplasia. – URL: https://www.sciencedirect.com/science/article/pii/S1476558626001077?dgcid=rss_sd_all
Engineering CAR-T cell therapies for digestive tract cancer: advances, challenges, and strategies to overcome tumor heterogeneity and immunosuppressive barriers. Neoplasia. https://www.sciencedirect.com/science/article/pii/S1476558626001077?dgcid=rss_sd_all
“Engineering CAR-T cell therapies for digestive tract cancer: advances, challenges, and strategies to overcome tumor heterogeneity and immunosuppressive barriers.” Neoplasia.
@article{article94785,
title = {Engineering CAR-T cell therapies for digestive tract cancer: advances, challenges, and strategies to overcome tumor heterogeneity and immunosuppressive barriers},
journal = {Neoplasia},
url = {https://www.sciencedirect.com/science/article/pii/S1476558626001077?dgcid=rss_sd_all}
}